Preventive Treatment for Household Contacts of Drug-Susceptible Tuberculosis Patients

被引:7
作者
Salazar-Austin, Nicole [1 ]
Mulder, Christiaan [2 ,3 ]
Hoddinott, Graeme [4 ]
Ryckman, Theresa [5 ]
Hanrahan, Colleen F. [5 ]
Velen, Kavindhran [6 ]
Chimoyi, Lucy [7 ]
Charalambous, Salome [7 ,8 ,9 ]
Chihota, Violet N. [7 ,8 ,10 ]
机构
[1] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21287 USA
[2] KNCV TB Fdn, Dept TB Eliminat & Hlth Syst Innovat, NL-2516 The Hague, Netherlands
[3] Univ Amsterdam, Amsterdam Inst Global Hlth & Dev, Med Ctr, NL-1105 Amsterdam, Netherlands
[4] Stellenbosch Univ, Fac Med & Hlth Sci, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, ZA-7500 Cape Town, South Africa
[5] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21287 USA
[6] Univ Sydney, Fac Med & Hlth, Cent Clin Sch, 90-92 Parramatta Rd, Sydney, NSW 2006, Australia
[7] Aurum Inst, ZA-2000 Johannesburg, South Africa
[8] Univ Witwatersrand, Sch Publ Hlth, ZA-2000 Johannesburg, South Africa
[9] Yale Sch Publ Hlth, Div Epidemiol Microbial Dis, New Haven, CT 06510 USA
[10] Vanderbilt Univ, Sch Med, Dept Med, Div Infect Dis, Nashville, TN 37240 USA
基金
美国国家卫生研究院;
关键词
TB infection; household contacts; TB preventive treatment; PULMONARY TUBERCULOSIS; WEEKLY RIFAPENTINE; COST-EFFECTIVENESS; CHILD CONTACTS; INFECTION; THERAPY; HIV; TRANSMISSION; BIOMARKER; ADULTS;
D O I
10.3390/pathogens11111258
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
People who live in the household of someone with infectious pulmonary tuberculosis are at a high risk of tuberculosis infection and subsequent progression to tuberculosis disease. These individuals are prioritized for contact investigation and tuberculosis preventive treatment (TPT). The treatment of TB infection is critical to prevent the progression of infection to disease and is prioritized in household contacts. Despite the availability of TPT, uptake in household contacts is poor. Multiple barriers prevent the optimal implementation of these policies. This manuscript lays out potential next steps for closing the policy-to-implementation gap in household contacts of all ages.
引用
收藏
页数:13
相关论文
共 55 条
[41]   Child contact management in high tuberculosis burden countries: A mixed-methods systematic review [J].
Szkwarko, Daria ;
Hirsch-Moverman, Yael ;
Du Plessis, Lienki ;
Du Preez, Karen ;
Carr, Catherine ;
Mandalakas, Anna M. .
PLOS ONE, 2017, 12 (08)
[42]   Active contact tracing beyond the household in multidrug resistant tuberculosis in Vietnam: a cohort study [J].
Thi Thanh Thuy Hoang ;
Viet Nhung Nguyen ;
Ngoc Sy Dinh ;
Thwaites, Guy ;
Thu Anh Nguyen ;
van Doorn, H. Rogier ;
Cobelens, Frank ;
Wertheim, Heiman F. L. .
BMC PUBLIC HEALTH, 2019, 19 (1)
[43]  
Unitaid, 2019, LANDM DEAL SEC SIGN
[44]  
Unitaid Partners, 2022, ANNOUNCE REDUCED PRI
[45]  
United Nations, 2019, UNITED END TUBERCULO
[46]   Child Contact Case Management-A Major Policy-Practice Gap in High-Burden Countries [J].
Vasiliu, Anca ;
Salazar-Austin, Nicole ;
Trajman, Anete ;
Lestari, Trisasi ;
Mtetwa, Godwin ;
Bonnet, Maryline ;
Casenghi, Martina .
PATHOGENS, 2022, 11 (01)
[47]   The effectiveness of contact investigation among contacts of tuberculosis patients: a systematic review and meta-analysis [J].
Velen, Kavindhran ;
Shingde, Rashmi Vijay ;
Ho, Jennifer ;
Fox, Greg James .
EUROPEAN RESPIRATORY JOURNAL, 2021, 58 (06)
[48]   Proportion of tuberculosis transmission that takes place in households in a high-incidence area [J].
Verver, S ;
Warren, RM ;
Munch, Z ;
Richardson, M ;
van der Spuy, GD ;
Borgdorff, MW ;
Behr, MA ;
Beyers, N ;
van Helden, PD .
LANCET, 2004, 363 (9404) :212-214
[49]   Treatment for Preventing Tuberculosis in Children and Adolescents A Randomized Clinical Trial of a 3-Month, 12-Dose Regimen of a Combination of Rifapentine and Isoniazid [J].
Villarino, M. Elsa ;
Scott, Nigel A. ;
Weis, Stephen E. ;
Weiner, Marc ;
Conde, Marcus B. ;
Jones, Brenda ;
Nachman, Sharon ;
Oliveira, Ricardo ;
Moro, Ruth N. ;
Shang, Nong ;
Goldberg, Stefan V. ;
Sterling, Timothy R. .
JAMA PEDIATRICS, 2015, 169 (03) :247-255
[50]  
WHO, 2018, LATENT TUBERCULOSIS